Perimeter Medical Imaging AI, Inc.
TSXV:PINK Stok Raporu
Perimeter Medical Imaging AI Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6 Perimeter Medical Imaging AI şirketinin kazançları yıllık ortalama -13.6% oranında azalırken, Medical Equipment sektörünün kazançları yıllık 13.2% oranında artan oldu. Gelirler yıllık ortalama 62.5% oranında artan oldu.
Anahtar bilgiler
-13.6%
Kazanç büyüme oranı
Medical Equipment Sektör Büyümesi -19.2% Gelir büyüme oranı 62.5% Özkaynak getirisi -114.8% Net Marj -1,631.8% Sonraki Kazanç Güncellemesi 14 Nov 2024
Yakın geçmiş performans güncellemeleri
Perimeter Medical Imaging AI, Inc. to Report Q3, 2024 Results on Nov 14, 2024 Nov 08
Second quarter 2024 earnings: EPS and revenues exceed analyst expectations Aug 16
Perimeter Medical Imaging AI, Inc. to Report Q2, 2024 Results on Aug 14, 2024 Aug 08
First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind May 16
Perimeter Medical Imaging AI, Inc. to Report Q1, 2024 Results on May 14, 2024 May 11
Full year 2023 earnings released: US$0.22 loss per share (vs US$0.16 loss in FY 2022) Apr 01
Tüm güncellemeleri göster
Perimeter Medical Imaging AI, Inc. to Report Q3, 2024 Results on Nov 14, 2024 Nov 08
Perimeter Medical Imaging AI, Inc., Annual General Meeting, Dec 12, 2024 Oct 14
New major risk - Shareholder dilution Oct 10 Perimeter Medical Imaging AI, Inc. announced that it has received CAD 11.893165 million in funding from SC Master Holdings, LLC Oct 10
New minor risk - Shareholder dilution Oct 02 Perimeter Medical Imaging AI, Inc. announced that it expects to receive CAD 13.513513 million in funding Sep 10
Second quarter 2024 earnings: EPS and revenues exceed analyst expectations Aug 16
Perimeter Medical Imaging AI, Inc. to Report Q2, 2024 Results on Aug 14, 2024 Aug 08
Perimeter Medical Imaging AI (CVE:PINK) Will Have To Spend Its Cash Wisely Jul 15
First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind May 16
Perimeter Medical Imaging AI, Inc. to Report Q1, 2024 Results on May 14, 2024 May 11
Consensus revenue estimates fall by 51% Apr 30
New major risk - Revenue and earnings growth Apr 29
Full year 2023 earnings released: US$0.22 loss per share (vs US$0.16 loss in FY 2022) Apr 01
We're Keeping An Eye On Perimeter Medical Imaging AI's (CVE:PINK) Cash Burn Rate Mar 23
Price target increased by 15% to CA$4.38 Mar 04
Perimeter Medical Imaging AI, Inc. Announces Results from New Study 1 Published in the Annals of Surgical Oncology Feb 20
New minor risk - Share price stability Feb 15
Perimeter Medical Imaging AI, Inc. Announces Expanded Commercial Presence Within National Healthcare Provider System with Follow-On Placement of Perimeter S-Series Oct At Additional Hospital Site Feb 08
Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Nov 17
Perimeter Medical Imaging AI, Inc. to Report Q3, 2023 Results on Nov 14, 2023 Nov 09 Perimeter Medical Imaging AI, Inc., Annual General Meeting, Dec 06, 2023
Price target increased by 21% to CA$4.63 Oct 27
Perimeter Medical Imaging Ai, Inc. Announces Patient Randomization Underway At Clinical Trial Site At Mayo Clinic in Florida Oct 12
Perimeter Medical Imaging AI, Inc. Announces Alignment with FDA on Key Elements of Ongoing Clinical Trial Sep 09
Consensus EPS estimates fall by 17%, revenue upgraded Sep 05
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Sep 01
Perimeter Medical Imaging AI, Inc. to Report Q2, 2023 Results on Aug 29, 2023 Aug 24
We Think Perimeter Medical Imaging AI (CVE:PINK) Needs To Drive Business Growth Carefully Aug 18 Perimeter Medical Imaging Ai, Inc. Announces Executive Changes
First quarter 2023 earnings released: CA$0.05 loss per share (vs CA$0.11 loss in 1Q 2022) May 27
Anthony Holler Resigns as a Director of Perimeter Medical Imaging AI, Inc May 24
Perimeter Medical Imaging AI, Inc. to Report Q1, 2023 Results on May 25, 2023 May 19
We're Not Very Worried About Perimeter Medical Imaging AI's (CVE:PINK) Cash Burn Rate Apr 26
Price target decreased by 12% to CA$3.56 Apr 19
Full year 2022 earnings: EPS in line with expectations, revenues disappoint Apr 12 Perimeter Medical Imaging Ai, Inc. Announces CFO Changes
Consensus forecasts updated Nov 26
Consensus forecasts updated Nov 22
Price target decreased to CA$4.06 Nov 18
Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Nov 16
High number of new directors Nov 16
Perimeter Medical Imaging AI, Inc. to Report Q3, 2022 Results on Nov 15, 2022 Nov 09
We Think Perimeter Medical Imaging AI (CVE:PINK) Needs To Drive Business Growth Carefully Oct 25
Perimeter Medical Imaging AI, Inc., Annual General Meeting, Oct 27, 2022 Sep 16
Consensus revenue estimates increase by 56% Aug 31
Second quarter 2022 earnings: EPS and revenues exceed analyst expectations Aug 25
Perimeter Medical Imaging AI, Inc. to Report Q2, 2022 Results on Aug 24, 2022 Aug 18
Here's Why We're Not Too Worried About Perimeter Medical Imaging AI's (CVE:PINK) Cash Burn Situation Jun 29
Perimeter Medical Imaging AI Appoints Kancherla to Board of Directors Jun 23
Consensus revenue estimates fall by 32% Jun 06
First quarter 2022 earnings: Revenues miss analyst expectations Jun 02
Perimeter Medical Imaging Ai Appoints Chris Scott as Chief Financial Officer Jun 02
Consensus EPS estimates fall by 21% May 09
High number of new directors Apr 27
Price target decreased to CA$5.42 Apr 06
Perimeter Medical Imaging AI Announces Initiation of Additional Clinical Trial Site at Baylor College of Medicine in Houston, TX Jan 12
Perimeter Medical Imaging AI Announces Initiation of First Clinical Trial Site At West Cancer Center & Research Institute in Tennessee Dec 17
Perimeter Medical Imaging AI, Inc. announced that it expects to receive CAD 43.400001 million in funding Dec 16
High number of new directors Dec 06
Consensus forecasts updated Jun 07
Consensus forecasts updated May 16
Director recently bought CA$215k worth of stock Mar 05
The Director of Perimeter Medical Imaging AI, Inc. (CVE:PINK), Douglas Janzen, Just Bought 60% More Shares Mar 05
Perimeter Medical Imaging AI Announces U.S. FDA 510(k) Clearance for OCT Imaging System Mar 03
New 90-day high: CA$4.09 Feb 27
New 90-day high: CA$3.28 Jan 29
New 90-day high: CA$2.90 Jan 13
New 90-day high: CA$2.62 Dec 25
New 90-day high: CA$2.50 Nov 28
Perimeter Medical Imaging AI nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi TSXV:PINK Gelir, gider ve kazançlar (USD Millions ) Tarih Gelir Kazançlar G+A Giderleri Ar-Ge Giderleri 30 Jun 24 1 -11 13 6 31 Mar 24 1 -13 12 5 31 Dec 23 1 -14 11 5 30 Sep 23 1 -12 9 5 30 Jun 23 1 -13 9 5 31 Mar 23 1 -8 10 6 31 Dec 22 0 -10 10 5 30 Sep 22 0 -11 13 5 30 Jun 22 0 -13 11 5 31 Mar 22 0 -15 10 4 31 Dec 21 0 -13 9 4 30 Sep 21 0 -11 8 5 30 Jun 21 0 -7 7 4 31 Mar 21 0 -8 7 3 31 Dec 20 0 -6 6 2 30 Sep 20 0 -6 5 0 30 Jun 20 0 -8 5 0 31 Mar 20 0 -7 5 1 31 Dec 19 0 -8 5 0 31 Dec 18 0 -5 4 0
Kaliteli Kazançlar: PINK şu anda kârlı değil.
Büyüyen Kar Marjı: PINK şu anda kârlı değil.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: PINK kârlı değildir ve zararlar son 5 yılda yılda 13.6% oranında artmıştır.
Büyüme Hızlandırma: PINK 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil
Kazançlar vs. Sektör: PINK kârlı olmadığından, geçmiş yıl kazanç büyümesinin Medical Equipment sektörüyle ( 11.7% ) karşılaştırılması zorlaşıyor.
Özkaynak Getirisi
Yüksek ROE: PINK hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi 'ne ( -114.78% ) sahiptir.
Kullanılan Sermaye Getirisi
Geçmişte güçlü performans gösteren şirketleri keşfedin Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
